Condition: Nocturia · Sponsor: Northwell Health
This is a single-center prospective pilot study of PureWick used as a management for nocturia and reduction of nighttime falls associated with going to the bathroom. Subjects are followed up to 3 months after the intervention. As a pilot study, it is expected that a 3-month follow-up will adequately capture urinary and sleep outcomes data and any adverse events related or unrelated to the study device.
This description comes directly from the study's public registry record.
Bilal Chughtai, MD · 516-628-5910 · bchughtai@northwell.edu
Jennifer Polo, CCRC · 516-628-5910 · Jpolo1@northwell.edu
Always discuss trial participation with your own doctor first.
| Weill Cornell Medicine | New York, New York, United States | Completed |
| Multi-Specialty NHPP Syosset | Syosset, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05090722